Kratom Science | 2021

Kratom's reputed pain-relief benefits could come from one of its metabolites.

June 1, 2019

Science News

Date:May 29, 2019Source:American Chemical Society Summary: Kratom is a Southeast Asian tree with a long history of use in traditional medicine. In the region, the plant's leaves are widely consumed for pain relief, treatment of opioid addiction and other uses. Though its efficacy and safety are unproven, kratom use has spread to the US and Europe. Now, researchers report that a metabolite of a kratom alkaloid could be responsible for the treatment's therapeutic effects.

Kratom is a Southeast Asian tree with a long history of use in traditional medicine. In the region, the plant's leaves are widely consumed for pain relief, treatment of opioid addiction and other uses. Though its efficacy and safety are unproven, kratom use has spread to the U.S. and Europe. Now, researchers report in ACS Central Science that a metabolite of a kratom alkaloid could be responsible for the treatment's therapeutic effects.

Currently, kratom is legal and available in the U.S. as a gray-market product, but it has an uncertain regulatory future. In the meantime, scientists are investigating the substance's physiological effects. Some prior research attributed these effects to mitragynine, the major active alkaloid in kratom, and its binding to an opioid receptor. However, 7-hydroxymitragynine (7-OH), another alkaloid present in the leaf at far lower concentrations, also interacts with that receptor. To clear up the matter, Jonathan A. Javitch, Susruta Majumdar, Dalibor Sames and colleagues set out to probe the pharmacological and metabolic mechanisms behind kratom's analgesic effects.

Through studies in cells and mice, the researchers showed that most of the analgesic effect is from 7-OH rather than mitragynine. They also found that metabolism of mitragynine in mouse and human liver preparations actually produces much more 7-OH than is present naturally in kratom. The team says that the results shed light on some of the seemingly contradictory reports on kratom, but more studies are still needed to see whether their findings in mice extend to humans.

Story Source:

Materials provided by American Chemical Society. Note: Content may be edited for style and length.

Journal Reference:

  1. Andrew C. Kruegel, Rajendra Uprety, Steven G. Grinnell, Cory Langreck, Elizabeth A. Pekarskaya, Valerie Le Rouzic, Michael Ansonoff, Madalee M. Gassaway, John E. Pintar, Gavril W. Pasternak, Jonathan A. Javitch, Susruta Majumdar, Dalibor Sames. 7-Hydroxymitragynine Is an Active Metabolite of Mitragynine and a Key Mediator of Its Analgesic Effects. ACS Central Science, 2019; DOI: 10.1021/acscentsci.9b00141

Original Article

Kratom Science | 2021 | kratom.com | info@kratom.com

New branding, same quality products

You'll be seeing quite a few changes within the Kratom.com brand, including an updated logo, packaging—and much more. We're celebrating 20 years in the industry and felt like it was time to freshen things up a bit. However, one thing that will always remain the same is the quality of our products. We'll always carry and supply the original Maeng Da™ and Bali Premium™—that we introduced to the market in 2001 as well as the service that you've come to expect. This is year come with some surprises that will go hand-in-hand with the new brand - for example, new value oriented savings opportunities for both consumers and our vendor and distributor partners, a NEW local Vendor Locator Map and or course a handful of exciting new products like our new Kratomade™ instant, flavored extracts and the first ever Salt-Based (SB-1™) extracts—two exciting game changers. As always, don't hesitate to reach out to us with any questions!

Info@kratom.com

Yours Truly,
The Kratom.com Team!

Get updates from Kratom.com

New product alerts, discounts and merch opps

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.